Clinical Trialblazers features high-profile biotech executives and investors in monthly conversations about leadership, funding, and drug development. This presents strong PR opportunities for guests to showcase expertise, milestones, and strategic vision to a scientifically engaged audience.
10 episodes, Monthly, 4.7 rating
<1k, Male, USA
Clinical Trialblazers invites you into the world of biotech leaders as they share the untold stories behind their journeys to bring breakthrough innovations to life. This 10 episode monthly series asks biotech visionaries to explore pivotal moments in their careers and the milestones that shaped their lives. Through unscripted conversations, host Alberto Grignolo dives into the decisions, risks, and accomplishments that define these trialblazers legacies to uncover the heart, grit, and ingenuity driving the future of scientific innovation.
Life Sciences, Science, Health & Fitness, Medicine, Business
Typical Credentials:
PhD or MD-level scientists or senior biotech executives; MBA/finance background common
Required Achievements:
CEO/Founder of biotech companies, venture capital leadership, board governance and chair roles, significant fundraising rounds, industry awards or recognitions
Geeta Vemuri - Venture Capital Journey; Building Successful Biotech Companies; Capital Efficiency; Board Membership; Science Vs Management; Future Of Biopharma, Miquel Vila-Perello - Academia To Biotech Transition; Fundraising Challenges; Investor Relations; Industry Vs Academia, Lyla Bibi - Biotech Investment Nuances; Trust In Leadership; Characteristics Of Successful Biotech Ceos; Value Of Leadership, Antti Vuolanto - CNS Diseases; Her096; Mentorship; Risk-taking; Investor Trust, Ross Breckenridge - Academia Vs Industry; European Clinical Trials; Cmc; Fundraising
biotech, venture capital, gene therapy, fundraising, leadership, board governance, drug development, pediatric oncology, CNS diseases, storytelling in science